WVNews | Business
FDA Approves Pfizer's Biosimilar, RUXIENCE (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions
West Virginia Business
•
Jul 23, 2019
Pfizer
Latest West Virginia stories tagged “Pfizer”.
WVNews | Business
WVNews | Business
Global Musculoskeletal Disorders Drugs Market Report 2019 Featuring F. Hoffmann-La Roche, GlaxosmithKline, Pfizer, Abbott Laboratories, Daiichi Sankyo - ResearchAndMarkets.com
West Virginia Business
•
Jul 23, 2019
WVNews | Business
We Are Pleased to Announce That Tanner Pharma Group Has Been Granted Direct Access to Procure Pfizer Medicines for European Clinical Trials Including Hospira Legacy...
West Virginia Business
•
Jul 23, 2019
WVNews | Business
Sangamo et Pfizer annoncent des rsultats de phase 1/2 mis jour pour la thrapie gnique exprimentale de l'hmophilie A, SB-525, qui indiquent des taux...
West Virginia Business
•
Jul 8, 2019
WVNews | Business
Sangamo and Pfizer Announce Updated Phase 1/2 Results for SB-525 Investigational Hemophilia A Gene Therapy Showing Sustained Increased Factor VIII Levels
West Virginia Business
•
Jul 6, 2019
WVNews | Business
Lorlatinib (Pfizer) Drug Overview 2017-2026 - ResearchAndMarkets.com
West Virginia Business
•
Jul 5, 2019
WVNews | Business
Pfizer Announces Results from Phase 3 Trial of Revatio (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension
West Virginia Business
•
Jun 28, 2019
WVNews | Business
Worldwide Generic Injectables Market Outlook 2019-2024 - Dominated by Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi, and Baxter - ResearchAndMarkets.com
West Virginia Business
•
Jun 28, 2019
WVNews | Business
Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy (DMD)
West Virginia Business
•
Jun 28, 2019
WVNews | Business
2019 Market Spotlight on Osteoarthritis & Osteoarthritis Pain - Pfizer Leads Industry Sponsors with the Highest Number of Clinical Trials for Osteoarthritis - ResearchAndMarkets.com
West Virginia Business
•
Jun 28, 2019
WVNews | Business
Pfizer Receives U.S. FDA Approval for Its Oncology Biosimilar, ZIRABEV (bevacizumab-bvzr)
West Virginia Business
•
Jun 28, 2019
WVNews | Business
Scott Gottlieb Elected to Pfizer's Board of Directors
West Virginia Business
•
Jun 27, 2019
WVNews | Business
Pfizer's Prevnar 13: Drug Overview, Product Profiles and Sales by Country (2017-2026) - ResearchAndMarkets.com
West Virginia Business
•
Jun 27, 2019
WVNews | Business
Synflorix (GlaxoSmithKline/Japan Vaccine) Drug Report 2018 - Market Share Will Continue to Decline as it Struggles to Compete with Prevnar 13 (Pfizer) in the EU & Japan...
West Virginia Business
•
Jun 27, 2019
WVNews | Business
Asia-Pacific Over the Counter (OTC) Drugs Market Report 2019-2024 with Key Player Profiles on Johnson & Johnson, Novartis, Bayer, GlaxoSmithKline, and Pfizer - ResearchAndMarkets.com
West Virginia Business
•
Jun 25, 2019
WVNews | Business
Real-World Data Capabilities: Benchmarking Pharma Companies (2019) Featuring Concerto HealthAI, IMI Harmony, J&J, Pfizer, Sanofi, and Teva - ResearchAndMarkets.com
West Virginia Business
•
Jun 25, 2019
WVNews | Business
Global Gastric Cancer Therapy Market (2019-2024): Major Players are F. Hoffmann-La Roche, Bristol-Myers Squibb, Pfizer, Merck & Co, and Celltrion - ResearchAndMarkets.com
West Virginia Business
•
Jun 24, 2019
WVNews | Business
Global Osteoarthritis Market 2013-2022 - Pfizer has the Highest Number of Completed & Total Clinical Trials, Followed by Merck & Co and Sanofi - ResearchAndMarkets.com
West Virginia Business
•
Jun 24, 2019
WVNews | Business
Bavencio (avelumab; Merck KGaA/Pfizer) Drug Profile 2018 - ResearchAndMarkets.com
West Virginia Business
•
Jun 20, 2019
WVNews | Business
Analysis on the Global Hormone Replacement Therapy Market 2019-2024 - Abbott, Bayer, Merck, Novartis, and Pfizer Hold the Largest Shares - ResearchAndMarkets.com
West Virginia Business
•
Jun 18, 2019
WVNews | Business
Pfizer Announces Results from XELJANZ XR (tofacitinib) ORAL Shift Study, The First Phase 3b/4 Study to Evaluate Methotrexate Withdrawal with a JAK Inhibitor
West Virginia Business
•
Jun 12, 2019
WVNews | Business
Jeff Settleman, Ph.D., Joins Pfizer to Lead Oncology Research & Development
West Virginia Business
•
Jun 5, 2019